The global ophthalmic imaging market size is calculated at USD 2.66 billion in 2024, grew to USD 2.83 billion in 2025, and is projected to reach around USD 4.83 billion by 2034. The market is expanding at a CAGR of 6.27% between 2025 and 2034.
FDA Approval: In February 2025, AI Optics announced that the U.S. Food and Drug Administration (FDA) approved its Sentinel Camera for retinal disease screening. Sentinel Camera is a handheld retinal imaging system that captures high-quality images without the need for dilation.
Increasing Collaboration: In February 2025, Optos announced a collaboration with Monaco to develop MonacoPro, a next-generation ultra-widefield scanning laser ophthalmology (SLO) and spectral domain retinal imaging solution. The solution enhances OCT image quality and improves diagnostic precision.
Researchers focus on developing innovative ophthalmic imaging devices by leveraging AI, ML, and large language models (LLMs) for real-time analysis of ophthalmic conditions to enhance the accuracy and precision, resulting in rapid outcomes.
Key Players: Syneos Health, Sectra Medical, and Topcon Corporation
Companies distribute their novel and innovative ophthalmic imaging devices to hospitals and clinics, enabling healthcare professionals to provide advanced patient care.
Key Players: Heidelberg Engineering, Remidio, Appasamy Associates, and Forus Health
Patient support & services in ophthalmic imaging include the use of portable and non-invasive ophthalmic devices for determining ocular disorders at affordable rates. It also refers to patient education and a smooth experience during the diagnostic process.
Key Players: Voiant Clinical, Clario, Carl Zeiss, and DAS Health
Ram Liebenthal, General Manager US at Heidelberg Engineering, commented that the FDA clearance of SPECTRALIS Flex Module fulfills the company’s vision of bringing Heidelberg image quality to all patients, regardless of their age or physical abilities. He also said that the module ensures patients have access to best-in-class imaging, offering peace of mind to parents, guardians, and caretakers.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
